{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-347315","form_type":"8-K","ticker":"OKUR","cik":"0001637715","company_name":"OnKure Therapeutics, Inc.","filed_at":"2026-08-12T22:22:46+00:00","discovered_at":"2026-08-13T10:05:00.695199+00:00","generated_at":"2026-08-13T10:05:37.270130+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"OnKure reprices underwater options to $4.14; ~1.7M shares affected","bullets":["Board approved repricing of eligible options with exercise price >= $10.00 to $4.14, effective Aug 7, 2026.","CEO Saccomano: 571,423 options repriced; CMO Agresta: 149,984; CFO Leverone: 141,714.","Repriced options total ~1.7M shares; original exercise prices ranged $13.99-$24.59.","Retention requirement: 18 months for senior management, 1 year for others; no change to term, vesting, or share count."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-347315","json":"https://secwatch.observer/filing/0001193125-26-347315.json","markdown":"https://secwatch.observer/filing/0001193125-26-347315.md","text":"https://secwatch.observer/filing/0001193125-26-347315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/0001193125-26-347315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/okur-20260807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T10:05:37.270130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}